Product category:
Clinical chemistry analysis
News Release from: Cisbio International
Edited by the Laboratorytalk Editorial
Team on 08 October 2007
Lumi4 complexes are incorporated in
Cisbio assays
Cisbio and Lumiphore Announce Partnership for New Product and Technology Development Incorporating Lumi4 Compounds.
Cisbio, a developer of HTRF (homogeneous time-resolved fluorescence) technology and services used in assay development and drug screening, and Lumiphore, an early-stage biotechnology company developing proprietary lanthanide technology for use in high-value applications, have signed an exclusive agreement for the incorporation of Lumiphore's Lumi4 complexes in Cisbio assays Under the agreement, Cisbio holds the exclusive rights to apply Lumi4 technology to current and future research and development initiatives in TR-Fret-based (time-resolved fluorescence resonance energy transfer) assays for drug discovery
This article was originally published on Laboratorytalk on 10 May 2005 at 8.00am (UK)
Related stories
First blood test for mesothelioma
Up until now, there have been no reliable serum tumour markers for mesothelioma, which means that diagnosis, screening and monitoring responses to treatment have been difficult
Assay development for GPCR-Gq screening
Homogeneous screening platform delivers precise and time-sensitive second messenger measurement, and also represents a novel functional means of precisely investigating GPCR mechanistics
Lumi4 compounds bring excellent photophysical properties, increased sensitivity and stability to TR-Fret assays for high-throughput screening (HTS) applications and the growing homogeneous assay market.
The incorporation of Lumi4 compounds to Cisbio's proprietary HTRF technology has the potential to enable the development of a second generation of assay platforms used in HTS, particularly in the fields of GPCR (G-protein coupled receptors) and kinase screening.
"This agreement represents a major step in our quest for highly performing TR-Fret assays," said Francois Degorce, head of HTRF marketing and business development, Cisbio.
Further reading
Assays incorporate small molecule organic dye
Optimisation of cyclic AMP (adenosine 3',5'-cyclic monophosphate) assay formats with d2 acceptor molecule complements existing assay to enhance G-protein coupled receptor (GPCR) platform
Upstate and Cisbio announce launch of HTRF Kinease
New kits for rapid kinase assay development mark second product collaboration between the two companies
"We strongly believe that Lumi4 compounds will enable us to widen our HTRF product portfolio and strengthen our leading position in this field".
HTRF is a highly sensitive, robust technology for the detection of molecular interactions of proteins in vitro and is widely used for primary and secondary screening phases of drug development.
HTRF combines standard Fret technology with time-resolved measurement of fluorescence.
During the Fret process, HTRF fluorophores emit long-lived fluorescence which can be discriminated from short-lived background fluorescence, boosting detection of these homogeneous assays.
Lumi4 complexes are a new class of fluorescent lanthanide detection reagents based on lanthanide technology patented by Professor Kenneth Raymond, chairman and president of Lumiphore, and coworkers at the University of California, Berkeley.
Lanthanides are used as reagents by researchers due to their strong luminescent properties, and these patents relate to a shell surrounding the lanthanide molecule which enables them to be used as extremely efficient Fret donors.
These complexes have long emission lifetimes and offer a number of major advantages over existing fluorophores used for detection, including higher signal-to-noise ratio and stability.
"Cisbio has an extensive HTRF product line and expertise in drug discovery research, and our agreement with them validates the capabilities of Lumiphore's technology," said Raymond.
"We look forward with excitement and enthusiasm to a productive partnership".
Combining the two technologies will allow for the development of new HTRF applications and increased possibilities for HTS implementation of Cisbio's assays. Request free introductory details about products from Cisbio International ...
• Cisbio International: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
